Group 1: Technology Innovation Mechanism - The company has established a mechanism for continuous technological innovation, guided by market demand and clinical needs [2] - A rapid after-sales service mechanism has been implemented to respond quickly to clinical feedback [2] - The marketing department collects industry dynamics through hospital visits, academic discussions, and market research, feeding this information back to the R&D department [2] Group 2: Collaborative Innovation - The company emphasizes independent innovation while maintaining open cooperation with multiple universities and research institutions [2] - A strong R&D team collaborates with renowned medical institutions and industry partners to enhance technological innovation [2] - The company has established a close "industry-university-research-medical" innovation mechanism to support technology innovation [2] Group 3: Talent Development - A comprehensive talent education and training mechanism is in place to ensure high overall R&D capabilities [3] - The company has established a targeted professional product knowledge training system within each product line [3] - Employees are encouraged to engage in self-directed learning to enhance their professional competencies and overall quality [3] Group 4: Marketing Strategy - The product line layout is based on the strategic positioning of being a "provider of micro-invasive surgical solutions," with synergistic effects among product lines [3] - The marketing model remains largely unchanged, which helps save marketing costs [3] - Adjustments are made to the marketing strategies of different product lines based on industry competitors to enhance market competitiveness [3] Group 5: Profit Margins - The overall gross profit margin of the company is maintained at around 70% [3] - To increase product penetration and market share, the company has lowered the selling price of surgical power device products, resulting in a slightly lower gross profit margin for this segment [3]
西山科技(688576) - 重庆西山科技股份有限公司2023年12月19日投资者关系活动记录表